- Home
- SAVA vs FOSL Comparison
SAVA vs FOSL Comparison
Compare SAVA & FOSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- FOSL
- Stock Information
- Founded
- SAVA 1998
- FOSL 1984
- Country
- SAVA United States
- FOSL United States
- Employees
- SAVA N/A
- FOSL N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- FOSL Consumer Specialties
- Sector
- SAVA Health Care
- FOSL Consumer Discretionary
- Exchange
- SAVA Nasdaq
- FOSL Nasdaq
- Market Cap
- SAVA 134.2M
- FOSL 112.2M
- IPO Year
- SAVA N/A
- FOSL 1993
- Fundamental
- Price
- SAVA $2.56
- FOSL $1.94
- Analyst Decision
- SAVA Buy
- FOSL
- Analyst Count
- SAVA 3
- FOSL 0
- Target Price
- SAVA $111.50
- FOSL N/A
- AVG Volume (30 Days)
- SAVA 12.4M
- FOSL 2.2M
- Earning Date
- SAVA 11-07-2024
- FOSL 11-07-2024
- Dividend Yield
- SAVA N/A
- FOSL N/A
- EPS Growth
- SAVA N/A
- FOSL N/A
- EPS
- SAVA N/A
- FOSL N/A
- Revenue
- SAVA N/A
- FOSL $1,223,954,000.00
- Revenue This Year
- SAVA N/A
- FOSL N/A
- Revenue Next Year
- SAVA N/A
- FOSL N/A
- P/E Ratio
- SAVA N/A
- FOSL N/A
- Revenue Growth
- SAVA N/A
- FOSL N/A
- 52 Week Low
- SAVA $2.55
- FOSL $0.75
- 52 Week High
- SAVA $42.20
- FOSL $2.61
- Technical
- Relative Strength Index (RSI)
- SAVA 22.85
- FOSL 59.04
- Support Level
- SAVA $2.78
- FOSL $1.81
- Resistance Level
- SAVA $3.28
- FOSL $2.06
- Average True Range (ATR)
- SAVA 0.26
- FOSL 0.23
- MACD
- SAVA 0.25
- FOSL -0.01
- Stochastic Oscillator
- SAVA 0.00
- FOSL 42.23
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About FOSL Fossil Group Inc.
Fossil Group Inc is a design, innovation and distribution company in consumer fashion accessories. The products include traditional watches, smartwatches, jewelry, handbags, small leather goods, belts and sunglasses. The reportable segments are comprised of 1) Americas segment includes sales in Canada, Latin America and the United States. 2) Europe segment includes sales in European countries, the Middle East and Africa. 3) Asia segment includes sales in Australia, China, India, Indonesia, Japan, Malaysia, New Zealand, Singapore, South Korea and Thailand. Each reportable operating segment includes sales to wholesale and distributor customers, and sales through Company-owned retail stores and e-commerce activities based on the location of the selling entity.